Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Genomic Health

Biotech & Life Sciences · Redwood City, United States · Founded 2000 · IPO 2005 Unicorn

About Genomic Health Genomic Health, Inc

Valuation
$2.80B
Market cap · 2026
Revenue
$394M
Latest reported FY
EBITDA
$86M
Latest reported FY

Investors

2 investors on Genomic Health's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
Series B+ 1 investor entered at this stage

Global footprint

Where Genomic Health has talent and traffic

AI talent share
0.3% of workforce is AI talent
(1 of 317 staff)
Core AI00%
Other AI10.32%
Non-AI workforce31699.68%
Workforce by country
10 countries with
team presence
🇺🇸 United States87.9%
🇨🇦 Canada3%
🇨🇭 Switzerland2.3%
🇵🇪 Peru0.8%
🇦🇷 Argentina0.8%
Top 5 of 10 shown
Web traffic by country
500 monthly visits
across markets
🇺🇸 United States100%
Top 1 markets shown

Patent intelligence

$64M patent portfolio · 23 active families

Estimated portfolio value
$64M
2.3% of market cap · smaller than top peer Exact Sciences ($319M)
23 active patent families
Where Genomic Health innovates OncologyCancer researchPathologyCarcinosisRNA

Where Genomic Health concentrates vs peers

Each axis is a top-10 topic across Genomic Health and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Genomic Health's 4 investments and acquisitions.

Every disclosed deal where Genomic Health appeared as a backer or acquirer, 2013–2018. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across Genomic Health's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Genomic Health deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Genomic Health's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        What the market is saying about Genomic Health

        An AI-synthesized read of the highest-engagement posts about Genomic Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Genomic Health on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.